Merck KGaA’s $11.3 Billion Bio-Techne Buy Bolsters CGT Ambitions in Biggest Deal Since 2014

Life Science

Why Apple’s AI-Fueled Price Shock Doesn’t Break Its Long-Term Investment Case

Consumer Goods, Technology

Intel and Sandisk Rally Sharply, Fueling Debate Over Divergent Downside Risks

Technology

Nvidia’s Photonics Bets Supercharge U.S. Optoelectronics Stocks

Technology

Cathie Wood Doubles Down on SpaceX (SPCX) Amid 25% Post-IPO Rout

Technology

SanDisk’s AI-Driven NAND Boom: Can It Really Hit $1 Trillion by 2027?

Technology

Reed Hastings Is Out and Netflix Is Down 32% — Should You Buy or Run?

Technology

The Federal Government’s $21 Billion Bet: Semiconductors, Rare Earths, and a New Kind of Industrial Policy

Mining, Technology

If the AI Trade Unwinds, What’s Actually the Best Safe Haven?

Cryptocurrency, Precious Metals, Technology

Walmart’s First Nuclear PPA: What It Signals About Corporate Energy’s Future

Consumer Goods, Energy

Everyone’s Selling Tech, Should You Be Buying Microsoft?

Technology

How Much Power Do AI Data Centers Need? Enough for Chevron to Build Microsoft a Dedicated Power Plant

Energy, Technology

Can Zumilokibart Become the Next Megablockbuster? Inside AbbVie’s $10.9 Billion Bet on Apogee

Life Science

Tech Tumbles as SpaceX Leads Selloff — These Two Dividend Kings Offer Calm Amid the Chaos

Consumer Goods, Technology

China Adds MP Materials, USA Rare Earth to Export Blacklist in Tit-for-Tat Move

Mining